Waters D - Search Results

1

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. Pitt B, et al. Among authors: waters d. N Engl J Med. 1999 Jul 8;341(2):70-6. doi: 10.1056/NEJM199907083410202. N Engl J Med. 1999. PMID: 10395630 Free article. Clinical Trial.

2

Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT).

McCormick LS, Black DM, Waters D, Brown WV, Pitt B. McCormick LS, et al. Among authors: waters d. Am J Cardiol. 1997 Nov 1;80(9):1130-3. doi: 10.1016/s0002-9149(97)00627-9. Am J Cardiol. 1997. PMID: 9359537 Clinical Trial.

3

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.

Rosenson RS, Hislop C, McConnell D, Elliott M, Stasiv Y, Wang N, Waters DD; PLASMA Investigators. Rosenson RS, et al. Among authors: waters dd. Lancet. 2009 Feb 21;373(9664):649-58. doi: 10.1016/S0140-6736(09)60403-7. Lancet. 2009. PMID: 19231633 Clinical Trial.

4

Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial.

Waters D. Waters D. Eur Heart J. 2000 Jul;21(13):1029-31. doi: 10.1053/euhj.1999.2015. Eur Heart J. 2000. PMID: 10843815 Review. No abstract available.

5

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators. Feldman HH, et al. Among authors: waters dd. Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3. Neurology. 2010. PMID: 20200346 Clinical Trial.

6

Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease.

Thompson GR, Hollyer J, Waters DD. Thompson GR, et al. Among authors: waters dd. Curr Opin Lipidol. 1995 Dec;6(6):386-8. doi: 10.1097/00041433-199512000-00010. Curr Opin Lipidol. 1995. PMID: 8750253

7

What do the statin trials tell us?

Waters DD. Waters DD. Am J Manag Care. 2001 May;7(5 Suppl):S138-43. Am J Manag Care. 2001. PMID: 11383375 Free article. Review.

8

Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD Council.

Verheugt FW, Becker RC, Bertrand ME, Bode C, Chesebro JH, Cleland JG, Conti R, Hillis WS, Klein W, Maseri A, Turpie AG, Wallentin L, Waters DD. Verheugt FW, et al. Among authors: waters dd. Clin Cardiol. 1999 Sep;22(9):551-3. doi: 10.1002/clc.4960220903. Clin Cardiol. 1999. PMID: 10486693 Free PMC article.

9

[Will heart catheters besides hospitalization also become superfluous?. Interview by Dr. med. Ulrike Wepner].

Waters D. Waters D. MMW Fortschr Med. 1999 Dec 9;141(49-50):62-4. MMW Fortschr Med. 1999. PMID: 10766551 German. No abstract available.

10

Differences in real-world outcomes by risk classification for localized prostate cancer patients after radiation therapy.

Karsh L, Du S, He J, Waters D, Muser E, Shore N. Karsh L, et al. Among authors: waters d. Prostate. 2024 Apr 29. doi: 10.1002/pros.24720. Online ahead of print. Prostate. 2024. PMID: 38685667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,383 results

Search Page